Comment by vikramkr

A lot of the new crop of biotech companies popping up in Philadelphia raised chinese money - one of the founders there told me it was because chinese investors had a "more enlightened view of valuations." I wonder how these changes will begin to affect biotech. Considering some of the recent intellectual property drama with chinese national employees, could there have been risks around IP from taking money from Shanghai based venture firms? It's a complicated issue as international financing always is, but I do wish people were allowed to invest anywhere/accept money from anywhere without government interference